Company recognized as “clinical trial innovator in patient engagement” for its efforts in enhancing participant experience through patient-facing solutions
King of Prussia, PA (May 3, 2023) – Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, today announced that it has been selected as the winner of the 2023 MedTech Breakthrough Award for “Clinical Trial Innovation in Patient Engagement.” This award marks the fourth consecutive win for Greenphire, signifying its continued excellence in solutions, client support and continued innovation.
With over 4,000 nominations in 2023 from across the globe, the MedTech Breakthrough Awards honor companies and innovative solutions that address a true need, solve a complex or critical problem, seize an opportunity, and create or revolutionize a new market or industry. Greenphire was selected for its continued dedication to improving the clinical trial patient experience globally, as part of an extensive and competitive industry evaluation.
The industry is asking for a solution which supports patient-neutral spend to enable equity, access and inclusion as part of their recruitment and diversity initiatives. Retaining participants in a trial continues to be a challenge with dropout rates hovering around 30-40%. This can be attributed in large part to the financial and travel burdens as well as time incurred that comes with participating in a clinical trial.
Greenphire’s patient-facing solutions have successfully enabled sponsors and clinical research sites to remove the financial and logistical burden from participants and their caregivers on a global scale.
“We are honored to receive recognition once again from MedTech Breakthrough,” said Jim Murphy, CEO, Greenphire. “Greenphire is committed to continuously enhancing the participant experience through purpose-built solutions which enable sponsors and clinical research sites to remove the financial and logistical burden from participants. We value the acknowledgment by our clients and industry organizations, in knowing we are moving the needle on our mission.”
In addition to the recognition from MedTech Breakthrough, Greenphire was recently recognized on the short list by the 2023 Citeline Awards for both best patient-facing technology initiative for Greenphire’s collaboration with Signant Health, and best sponsor-facing technology initiative for EnvisiX, the industry’s most disruptive clinical trial budget negotiation software.
Greenphire recently announced the expansion of its participant-centered solution suite including the launch of a new patient-facing digital platform, GreenSpace, as well as expanded international payment functionality and flexibility, dramatically improving access, engagement, and retention globally.
About Greenphire
Greenphire’s suite of best-in-class technology solutions enables clients to prioritize the patient journey, so treatments and cures can be delivered to those who need them faster.
Committed to modernizing and integrating each step in the participant journey and the overall clinical trial lifecycle, Greenphire has established an unmatched suite of patient convenience solutions, including a mobile-enabled technology platform which offers a personalized and empowering end-to-end participant experience from trial identification (patient registry) through participation. ClinCard® and ConneX® remove financial and logistical barriers, simplifying the delivery of global patient convenience initiatives and improving recruitment and retention. Greenphire’s EnvisiX™ and eClinicalGPS® transform the budgeting and site payment process, resulting in expedited study start up and improved site sustainability. Learn more at www.greenphire.com
